Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Phase IIa Trial Evaluating the Safety and Efficacy of a New Centrally Acting Analgesic in Subjects With Moderate to Severe Pain Following Bunionectomy.

NCT00872885 is registered in ClinicalTrials.gov with Tris Pharma, Inc. as lead sponsor.

NCT NCT00872885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00872885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Phase IIa Trial Evaluating the Safety and Efficacy of a New Centrally Acting Analgesic in Subjects With Moderate to Severe Pain Following Bunionectomy.
Lead sponsor
Tris Pharma, Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2009
Completion date
October 31, 2009
Enrollment
258 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post operative pain